Decreased risk of hepatocellular carcinoma recurrence with direct-acting antivirals compared with no treatment for hepatitis C: a meta-analysis

BACKGROUND: Studies investigating the association between direct-acting antivirals (DAAs) and the recurrence of hepatocellular carcinoma (HCC) related to hepatitis C (HCV) have yielded conflicting results. The objective of this meta-analysis was to define the short- and long-term recurrence rates of...

Descripción completa

Detalles Bibliográficos
Autores principales: Lui, Felix H., Moosvi, Zain, Patel, Anish, Hussain, Samiya, Duong, Alex, Duong, Jacqueline, Nguyen, Douglas L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196608/
https://www.ncbi.nlm.nih.gov/pubmed/32382233
http://dx.doi.org/10.20524/aog.2020.0470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196608/
https://www.ncbi.nlm.nih.gov/pubmed/32382233
http://dx.doi.org/10.20524/aog.2020.0470

Ejemplares similares